Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

875 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael Scholz.
Sørensen BS, Overgaard J, Bassler N. Sørensen BS, et al. Acta Oncol. 2013 Apr;52(3):591. doi: 10.3109/0284186X.2013.767985. Epub 2013 Feb 19. Acta Oncol. 2013. PMID: 23421927 No abstract available.
Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation.
Nielsen S, Bassler N, Grzanka L, Swakon J, Olko P, Andreassen CN, Overgaard J, Alsner J, Sørensen BS. Nielsen S, et al. Acta Oncol. 2017 Nov;56(11):1406-1412. doi: 10.1080/0284186X.2017.1351623. Epub 2017 Sep 8. Acta Oncol. 2017. PMID: 28885067
Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study.
Thorsen LB, Thomsen MS, Overgaard M, Overgaard J, Offersen BV; Danish Breast Cancer Cooperative Group Radiotherapy Committee. Thorsen LB, et al. Acta Oncol. 2013 Oct;52(7):1526-34. doi: 10.3109/0284186X.2013.813643. Epub 2013 Aug 19. Acta Oncol. 2013. PMID: 23957621
Rethink radiotherapy - BIGART 2017.
Grau C, Høyer M, Poulsen PR, Muren LP, Korreman SS, Tanderup K, Lindegaard JC, Alsner J, Overgaard J. Grau C, et al. Acta Oncol. 2017 Nov;56(11):1341-1352. doi: 10.1080/0284186X.2017.1371326. Acta Oncol. 2017. PMID: 29148908 No abstract available.
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
Hassan Metwally MA, Ali R, Kuddu M, Shouman T, Strojan P, Overgaard J, Grau C. Hassan Metwally MA, et al. Acta Oncol. 2015;54(9):1673-7. doi: 10.3109/0284186X.2015.1074721. Epub 2015 Sep 23. Acta Oncol. 2015. PMID: 26397148 No abstract available.
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J. Bentzen J, et al. Acta Oncol. 2015 Jul;54(7):1001-7. doi: 10.3109/0284186X.2014.992547. Epub 2015 Jan 28. Acta Oncol. 2015. PMID: 25629651 Clinical Trial.
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
Tramm T, Kyndi M, Myhre S, Nord S, Alsner J, Sørensen FB, Sørlie T, Overgaard J. Tramm T, et al. Acta Oncol. 2014 Oct;53(10):1337-46. doi: 10.3109/0284186X.2014.925580. Epub 2014 Jun 24. Acta Oncol. 2014. PMID: 24957550 Clinical Trial.
LET-painting increases tumour control probability in hypoxic tumours.
Bassler N, Toftegaard J, Lühr A, Sørensen BS, Scifoni E, Krämer M, Jäkel O, Mortensen LS, Overgaard J, Petersen JB. Bassler N, et al. Acta Oncol. 2014 Jan;53(1):25-32. doi: 10.3109/0284186X.2013.832835. Epub 2013 Sep 10. Acta Oncol. 2014. PMID: 24020629
Lean body mass and muscle function in head and neck cancer patients and healthy individuals--results from the DAHANCA 25 study.
Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Overgaard J, Overgaard K. Lønbro S, et al. Acta Oncol. 2013 Oct;52(7):1543-51. doi: 10.3109/0284186X.2013.822553. Epub 2013 Aug 22. Acta Oncol. 2013. PMID: 23964657 Clinical Trial.
875 results
Jump to page